Registry for children, adolescents and adults with Osteosarcoma and biologically related bone sarcomas (COSS-Registry)

Suspended

• Conditions: Malignant high-grade osteosarcoma subtypes (conventional: osteoblastic, chondroblastic, fibroblastic, giant cell rich, osteoblastom-like, epithelioid, clear cell, chondroblastom-like; non-conventional: telangiectatic, small cell, high-grade surface), periosteal, parosteal, extra-skeletal, low-grade central, undifferentiated pleomorphic sarcoma, osseous leiomysarcoma, osseous dedifferentiated chondrosarcoma, osseous mesenchymal chondrosarcoma, osseous fibrosarcoma, osseous angiosarcoma

• Registration Number: DRKS00027990
• Lead Sponsor: Klinikum der Landeshauptstadt Stuttgart gKAöRZentrum für Kinder-, Jugend- und Frauenmedizin Standort Mitte (Olgahospital) Pädiatrie 5 (Onkologie, Hämatologie, Immunologie)Cooperative Osteosarkom Studiengruppe (COSS)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-02-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Suspended
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

All patients regardless of gender, age, tumor stage, current or future clinical trial participation with histologically proven diagnosis of one of the following tumors: Malignant high-grade osteosarcoma subtypes (conventional: osteoblastic, chondroblastic, fibroblastic, giant cell rich, osteoblastom-like, epithelioid, clear cell, chondroblastom-like; non-conventional: telangiectatic, small cell, high-grade surface), periosteal, parosteal, extra-skeletal, low-grade central, undifferentiated pleomorphic sarcoma, osseous leiomysarcoma, osseous dedifferentiated chondrosarcoma, osseous mesenchymal chondrosarcoma, osseous fibrosarcoma, osseous angiosarcoma
- Obtained informed consent of the patient and/or his/her legal guardian(s)

Exclusion Criteria

- No information and informed consent of the patient and/or the legal guardian

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Aims of the registry are the collection of clinical and epidemiologic data.

Secondary Outcome Measures

Name	Time	Method
/Overall-Survival